Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort | Zendy

Maryam Kavousi | Zendy; Maarten J.G. Leening | Zendy; David Nanchen | Zendy; Philip Greenland | Zendy; Ian Graham | Zendy; Ewout W. Steyerberg | Zendy; M. Arfan Ikram | Zendy; Bruno H. Stricker | Zendy; Albert Hofman | Zendy; Oscar H. Franco | Zendy

Open Access

Comparison of Application of the ACC/AHA Guidelines, Adult Treatment Panel III Guidelines, and European Society of Cardiology Guidelines for Cardiovascular Disease Prevention in a European Cohort

Author(s) -

Maryam Kavousi,

Maarten J.G. Leening,

David Nanchen,

Philip Greenland,

Ian Graham,

Ewout W. Steyerberg,

M. Arfan Ikram,

Bruno H. Stricker,

Albert Hofman,

Oscar H. Franco

Publication year - 2014

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2014.2632

Subject(s) - medicine , guideline , myocardial infarction , cohort , population , atherosclerotic cardiovascular disease , cardiology , stroke (engine) , cohort study , disease , pathology , mechanical engineering , environmental health , engineering

The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines introduced a prediction model and lowered the threshold for treatment with statins to a 7.5% 10-year hard atherosclerotic cardiovascular disease (ASCVD) risk. Implications of the new guideline's threshold and model have not been addressed in non-US populations or compared with previous guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research